Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab as a First-line Treatment for Diffuse Large B-Cell Lymphoma Life Science Investing
Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLO to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome Life Science Investing
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635 Life Science Investing
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 Life Science Investing
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer Life Science Investing
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
NRx Pharmaceuticals and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions Life Science Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
